2023
DOI: 10.1128/spectrum.00960-22
|View full text |Cite
|
Sign up to set email alerts
|

Malaria Molecular Surveillance in the Peruvian Amazon with a Novel Highly Multiplexed Plasmodium falciparum AmpliSeq Assay

Abstract: While the power of next-generation sequencing technologies to inform and guide malaria control programs has become broadly recognized, the integration of genomic data for operational incorporation into malaria surveillance remains a challenge in most countries where malaria is endemic. The main obstacles include limited infrastructure, limited access to high-throughput sequencing facilities, and the need for local capacity to run an in-country analysis of genomes at a large-enough scale to be informative for s… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
36
1

Year Published

2023
2023
2025
2025

Publication Types

Select...
5
3

Relationship

3
5

Authors

Journals

citations
Cited by 23 publications
(65 citation statements)
references
References 127 publications
3
36
1
Order By: Relevance
“…To design a SNP barcode with in-country resolution in Peru, raw whole genome sequencing data (Fast Q files) of P. vivax isolates from Peru generated in-house (n=30 from [23, 24]) was combined with online available Peruvian P. vivax genomes (n=100 from [2528]) and jointly genotyped after variant calling as described elsewhere [17]. Briefly, FASTQ files were aligned to the PvP01 reference genome version 46 from PlasmoDB [29] and variants were called using GATK4 HaplotypeCaller.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…To design a SNP barcode with in-country resolution in Peru, raw whole genome sequencing data (Fast Q files) of P. vivax isolates from Peru generated in-house (n=30 from [23, 24]) was combined with online available Peruvian P. vivax genomes (n=100 from [2528]) and jointly genotyped after variant calling as described elsewhere [17]. Briefly, FASTQ files were aligned to the PvP01 reference genome version 46 from PlasmoDB [29] and variants were called using GATK4 HaplotypeCaller.…”
Section: Methodsmentioning
confidence: 99%
“…Previously, we have developed a highly-multiplexed amplicon sequencing (AmpliSeq) assay for malaria genomic surveillance of P. falciparum in Peru (Pf AmpliSeq Peru, [22]) and P. vivax in Vietnam (Pv AmpliSeq v1 Vietnam, [23]). Our assays include validated and candidate genes associated with antimalarial resistance, SNP-barcodes to serve different functions, i.e.…”
Section: Introductionmentioning
confidence: 99%
“…However, for pathogens with larger genomes such as the malaria parasite, Plasmodium falciparum 2 , targeted genotyping approaches are more affordable and scalable. Panels of single nucleotide polymorphisms (SNPs) referred as "SNP barcodes" have been increasingly used for malaria genomic surveillance [3][4][5][6][7][8] . For malaria genomic surveillance to reach its full potential however, assessment of the capabilities and resolution of these genotyping tools is essential 9 .…”
Section: Mainmentioning
confidence: 99%
“…Alternative approaches are urgently needed to estimate genome-wide relatedness and define population structure at a similar resolution to WGS but for a fraction of the cost. Previous approaches have included panels of 10-14 polymorphic microsatellites [10], or barcodes comprising 24 [29], 28 [3], 54 [30] or 101 single nucleotide polymorphisms (SNPs) [6]. However, these genotyping tools lacked the required accuracy or spatial resolution to define local parasite populations, especially where the barcodes contained too few SNPs to accurately capture genome-wide relatedness [16,[31][32][33].…”
Section: Introductionmentioning
confidence: 99%
“…2). Genetic loci were selected according to a 24 SNP panel [20], a 101 SNP panel [21], and 3 recently developed amplicon sequencing panels consisting of 128 [13], 165 [22], and 233 [14] diverse microhaplotypes respectively. These simulations were done at moderate false positive and false negative rates of .01 and .1 respectively.…”
Section: Estimation Of Multiplicity Of Infection Within-host Relatedn...mentioning
confidence: 99%